Global Human Insulin Market 2011-2015
by ReportLinker.com on Aug 01, 2012
- 29 views
TechNavio's analysts forecast the Global Human Insulin market to grow at a CAGR of -4.02 percent over the period 2011-2015. One of the key factors contributing to this market growth is the significant ...
TechNavio's analysts forecast the Global Human Insulin market to grow at a CAGR of -4.02 percent over the period 2011-2015. One of the key factors contributing to this market growth is the significant increase in the number of patients suffering from diabetes and diabetes-related diseases worldwide. The Global Human Insulin market has also been witnessing the trend of rapid growth in the APAC region. However, the increased risk of cancer with human insulin use could pose a challenge to the growth of this market. TechNavio's report, the Global Human Insulin Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Insulin market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this market space include Bayer Healthcare AG, Eli Lilly & Co., Novo Nordisk A/S, and Sanofi S.A. Other vendors mentioned in the report: Abbott Laboratories Inc., Wockhardt Ltd., Piramal Healthcare Ltd., Glenmark Pharmaceuticals Ltd., SciGen Ltd., Tonghua Dongbao Pharmaceutical Co. Ltd., Gan & Lee Pharmaceutical Ltd., Wangbang Pharma Group Corp., and Pfizer Inc. Key questions answered in this report: What will the market size be in 2015 and at what rate will it grow' What key trends is this market subject to' What is driving this market' What are the challenges to market growth' Who are the key vendors in this market space' What are the opportunities and threats faced by each of these key vendors' What are the strengths and weaknesses of each of these key vendors' You can request one free hour of analyst time when you purchase this report. Details provided within the report.